Patents by Inventor Daniel Hoft

Daniel Hoft has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides for inducing Chagas disease responses
    Patent number: 10821164
    Abstract: The present disclosure relates to vaccine formulations and their use in treating and preventing Chagas Disease.
    Type: Grant
    Filed: June 6, 2016
    Date of Patent: November 3, 2020
    Assignees: Saint Louis University, EPIVAX, INC.
    Inventors: Daniel Hoft, Chris Eickhoff, Annie De Groot
  • PEPTIDES FOR INDUCING CHAGAS DISEASE RESPONSES
    Publication number: 20180185462
    Abstract: The present disclosure relates to vaccine formulations and their use in treating and preventing Chagas Disease.
    Type: Application
    Filed: June 6, 2016
    Publication date: July 5, 2018
    Inventors: Daniel HOFT, Chris EICKHOFF, Annie DE GROOT
  • Peptides for inducing heterosubtypic influenza T cell responses
    Patent number: 9265822
    Abstract: The present invention provides compositions and methods for generation of an anti-influenza immune response. In particular, conserved T cell epitopes within matrix protein and nucleoprotein components of influenza virus have been identified and further screened for those structures that will bind either or both of HLA I and II molecules. Methods for vaccinating subjects with formulations of such peptides for the treatment or prevention of influenza infaction also are described.
    Type: Grant
    Filed: September 30, 2010
    Date of Patent: February 23, 2016
    Assignee: Saint Louis University
    Inventor: Daniel Hoft
  • Peptides for Inducing Heterosubtypic Influenza T Cell Responses
    Publication number: 20110076297
    Abstract: The present invention provides compositions and methods for generation of an anti-influenza immune response. In particular, conserved T cell epitopes within matrix protein and nucleoprotein components of influenza virus have been identified and further screened for those structures that will bind either or both of HLA I and II molecules. Methods for vaccinating subjects with formulations of such peptides for the treatment or prevention of influenza infaction also are described.
    Type: Application
    Filed: September 30, 2010
    Publication date: March 31, 2011
    Applicant: Saint Louis University
    Inventor: Daniel Hoft